protein drinks

3 articles
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Beyond Meat's Protein Pivot: Strategic Shift or Survival Gambit?

Beyond Meat pivots to protein drinks amid declining sales and delisting risk, targeting GLP-1 drug trends but facing competition from giants like PepsiCo's Muscle Milk.
BYNDPEPprofitabilityGLP-1 drugs
Investing.comInvesting.com··Thomas Hughes

Beyond Meat's Existential Crisis: Revenue Collapse Raises Delisting Risk

Beyond Meat reports 20% revenue decline to $61.59M in Q4 2025, missing estimates. Stock faces delisting threat with profitability unlikely until early 2030s.
BYNDQ4 2025 earningsrevenue decline
The Motley FoolThe Motley Fool··David Jagielski, Cpa

Beyond Meat's 78% Crash Leaves Stock Deep in Value Territory—But Recovery Far From Certain

Beyond Meat stock crashed 78% in 2025 as revenue declined 14% and operating losses doubled to $203.4M, leaving analysts cautious despite cheap $400M valuation.
BYNDstock declinevaluation